Seer
About:
Seer is a biotechnology company that offers tools and solutions related to the field of proteomics.
Website: https://seer.bio/
Twitter/X: seer_bio
Top Investors: Fidelity, Invus, Wing Venture Capital, Emerson Collective, Maverick Ventures
Description:
Seer is a developer of a life sciences and health data platform intended to facilitate early, pre-symptomatic detection of chronic life-threatening diseases. The company's platform captures and translates molecular insights from the proteome with improved accuracy and speed, enabling healthcare professionals to detect cancer and neurological diseases, drive earlier treatment and improve patient outcomes.
$170M
$10M to $50M
Redwood City, California, United States
2017-01-01
info(AT)seer.bio
Omid Farokhzad, Philip Ma
101-250
2020-07-22
Public
© 2025 bioDAO.ai